Elevance Health, Inc. (ELV)
NYSE:ELV
Want to see ELV full AI Analyst Report?
ELV Stock Chart & Stats
$323.05
<$0.01(<0.01%)
At close: 4:00 PM EST
$323.05
<$0.01(<0.01%)
Day’s Range― - ―
52-Week Range$273.71 - $408.00
Previous CloseN/A
Volume477.50K
Average Volume (3M)1.76M
Market Cap
$84.48B
Enterprise Value$107.57B
Total Cash (Recent Filing)$35.56B
Total Debt (Recent Filing)$31.84B
Price to Earnings (P/E)16.4
Beta0.43
Next Earnings
Jul 22, 2026EPS Estimate
6.2Next Dividend Ex-DateN/A
Dividend Yield1.99%
Share Statistics
EPS (TTM)23.51
Shares Outstanding217,162,380
10 Day Avg. Volume1,565,469
30 Day Avg. Volume1,764,631
Financial Highlights & Ratios
PEG Ratio-5.63
Price to Book (P/B)1.77
Price to Sales (P/S)0.39
P/FCF Ratio24.50
Enterprise Value/Market Cap1.27
Enterprise Value/Revenue0.54
Enterprise Value/Gross Profit2.32
Enterprise Value/Ebitda12.06
Forecast
1Y Price Target
$408.72Price Target Upside26.52% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering18
EPS Forecast (FY)26.85
Revenue Forecast (FY)$194.90B
Bulls Say, Bears Say
Bulls Say
Scale And Durable Revenue GrowthA large, diversified premium base across Commercial, Medicaid and Medicare has driven steady top-line expansion. Scale supports provider contracting leverage, spreads fixed costs, and sustains underwriting and fee revenue durability—strengthening competitive position over multiple market cycles.
Improved Cash Generation And FCF ReboundA meaningful TTM rebound in operating cash flow and free cash flow enhances financial flexibility to fund investments, share repurchases, and reserves. Strong cash conversion relative to earnings supports multi‑period capital allocation and resilience through healthcare cycle volatility.
Integrated Clinical Services With Measurable OutcomesDemonstrable clinical outcomes from integrated Carelon programs validate value‑based care offerings, improving client retention and opening risk-based contracts. Tangible savings and readmission reductions underpin durable demand for whole‑person care and strengthen long‑term margin potential in services.
Bears Say
Regulatory Risk From CMS MatterA $935M accrual and active CMS review create persistent regulatory and timing uncertainty. Potential settlements, sanctions or restrictions on MA/Part D enrollments could materially affect cash flows, enrollment trends and operational planning for several quarters, complicating medium‑term execution.
Margin Compression And Medicaid PressureMulti‑year margin erosion and guided negative Medicaid margins reflect structural cost inflation and eligibility shifts. Weaker profitability in government programs reduces earnings durability and free cash flow cushions, limiting reinvestment and amplifying sensitivity to utilization and pricing gaps.
Balance-sheet Reporting InconsistencyAn apparent debt discontinuity undermines confidence in leverage and liquidity assessment. Unclear true indebtedness hampers evaluation of covenant headroom, borrowing capacity and capital allocation durability, creating structural uncertainty until reconciled in audited disclosures.
Elevance Health News
ELV FAQ
What was Elevance Health, Inc.’s price range in the past 12 months?
Elevance Health, Inc. lowest stock price was $273.71 and its highest was $408.00 in the past 12 months.
What is Elevance Health, Inc.’s market cap?
Elevance Health, Inc.’s market cap is $84.48B.
When is Elevance Health, Inc.’s upcoming earnings report date?
Elevance Health, Inc.’s upcoming earnings report date is Jul 22, 2026 which is in 48 days.
How were Elevance Health, Inc.’s earnings last quarter?
Elevance Health, Inc. released its earnings results on Apr 22, 2026. The company reported $12.58 earnings per share for the quarter, beating the consensus estimate of $10.819 by $1.761.
Is Elevance Health, Inc. overvalued?
According to Wall Street analysts Elevance Health, Inc.’s price is currently Undervalued.
Does Elevance Health, Inc. pay dividends?
Elevance Health, Inc. pays a Quarterly dividend of $1.71 which represents an annual dividend yield of 1.99%. See more information on Elevance Health, Inc. dividends here
What is Elevance Health, Inc.’s EPS estimate?
Elevance Health, Inc.’s EPS estimate is 6.2.
How many shares outstanding does Elevance Health, Inc. have?
Elevance Health, Inc. has 217,162,380 shares outstanding.
What happened to Elevance Health, Inc.’s price movement after its last earnings report?
Elevance Health, Inc. reported an EPS of $12.58 in its last earnings report, beating expectations of $10.819. Following the earnings report the stock price went up 0.027%.
Which hedge fund is a major shareholder of Elevance Health, Inc.?
Currently, no hedge funds are holding shares in ELV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Elevance Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$408.72 (26.52% Upside)
$408.72 (26.52% Upside)
Blogger Sentiment
Bullish
ELV Sentiment 90%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 264.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $665.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.5%
Last 30 Days ▼ 5.8%
Last 30 Days ▼ 5.8%
News Sentiment
Bullish
Bullish news 75%
Bearish news 25%
Bearish news 25%
Technicals
SMA
Positive
20 days / 200 days
Momentum
5.38%
12-Months-Change
Fundamentals
Return on Equity
11.95%
Trailing 12-Months
Asset Growth
5.10%
Trailing 12-Months
Company Description
Elevance Health, Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
ELV Company Deck
ELV Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong execution and tangible operational improvements that drove a Q1 EPS beat, an upgraded full-year EPS guide, share repurchases and growing demand for integrated clinical and pharmacy offerings. Management also highlighted meaningful AI investments and measurable clinical results from Carelon/CareBridge (20% readmission reduction, >10% post-acute savings). Offsetting these positives are a material $935 million accrual related to a CMS historical risk-adjustment matter, a $129 million optimization charge, ongoing elevated Medicaid cost trends and some margin pressure and investment-driven cadence at Carelon. On balance the positives (guidance raise, underlying business beats, membership growth, cash generation and scalable AI/Carelon proof points) outweigh the negatives (one-time accrual, Medicaid pressure, Carelon margin timing), supporting a constructive outlook with manageable risks.View all ELV earnings summariesELV Stock 12 Month Forecast
Average Price Target
$408.72
▲(26.52% Upside)
Technical Analysis
Ownership Overview
0.17% Insiders
27.19% Mutual Funds
26.43% Other Institutional Investors
20.60% Public Companies and Individual Investors